Gapping up
In reaction to strong earnings/guidance: FCEL +18.3%, PME +16.7%, (light volume), POWR +16% (light volume), PWRD +9.4%, NVAX +9.2% (light volume), EJ +8.6%, PLOW +5.4%, HIL +4.6%, ARCO +3%, CISG +2.6%, ROYL +2.3% (thinly traded), ONTX +2% (light volume)
M&A news: TMUS +2% ( Softbank still attempting to buy TMUS and merge it with Sprint, according to reports).
Select metals/mining stocks trading higher: GFI +1.8%, SLV +1.5%, SLW +1.2%, AUY +1.2%, GG +1.2%, GDX +1.1%, GOLD +0.8%.
Battery related names seeing continued momentum: CPST +12.2%, PLUG +11.5%, BLDP +10.5%, CBAK +2.5%
Other news: LJPC +63.9% (reports positive, top-line results from Phase 2 Clinical Trial of GCS-100 in chronic kidney disease; primary efficacy endpoint of improved kidney function achieved), RCON +22.6% (Recon Technology's BHD division receives new authorization to provide fracturing equipment and services for SinopeC), HOTR +19.3% (modestly rebounding), DSS +11.6% (files patent infringement claim against Samsung (SSNLF), TSMC, and NEC), UQM +10.4% (continued strength), BYD +8.5% (Elliott Associates and Elliott International disclosed a combined 4.99% stake), RGSE +7.1% (continued strength), RNN +6.4% (Announces Initial Results from Phase I Trial of Supinoxin (RX-5902) for Solid Cancer Tumors; Supinoxin is safe and well tolerated over the dose range tested in cancer patients), PPHM +4.2% ( Data Presentations at Keystone Symposium Support Potential of co's PS-Targeting Antibodies to Overcome Immune Suppression and Enhance Anti-Tumor Activity of Anti-CTLA-4 and PD-1 Antibodies), GTAT +2.9% (Signs Agreement to Supply $336 Million of Equipment and Technology for a 25,000 MTA Polysilicon Production Facility in Sarawak, Malaysia), EXXI +1.7% ( positive comments on Mad Money), BBRY +1.3% (has sold its US HQ in Las Colinas, according to reports), KYTH +1.1% (acquired rights to ATX-101 outside of the U.S. and Canada from Bayer (BAYRY) Consumer Care), MSG +0.8% ( Sean 'Diddy' Combs bid ~$200 mln for the MSG owned Fuse cable-TV channel, according to reports), DATA +0.4% ( JANA Partners discloses sale of 2 mln shares at $68 on 3/6).
Analyst comments: JCP +6.9% (upgraded to Buy from Neutral at Citigroup), ITMN +4% (upgraded to Buy from Neutral at Goldman), DDD +2.7% ( upgraded to Overweight from Equal Weight at a boutique firm), GWPH +2.1% (initiated with a Buy at BofA/Merrill), ARO +1.4% ( initiated with a Buy at Buckingham Research), BLOX +0.9% (Infoblox initiated with an Overweight at Piper Jaffray),M +0.8% (upgraded to Outperform from Market Perform at Wells Fargo), AAPL +0.7% (upgraded to Outperform from Sector Perform at Pacific Crest), FB +0.7% (target raised to $85 from $70 at Citigroup), RFMD +0.7% ( initiated with a Buy at Ascendiant Capital Markets)
M&A news: TMUS +2% ( Softbank still attempting to buy TMUS and merge it with Sprint, according to reports).
Select metals/mining stocks trading higher: GFI +1.8%, SLV +1.5%, SLW +1.2%, AUY +1.2%, GG +1.2%, GDX +1.1%, GOLD +0.8%.
Battery related names seeing continued momentum: CPST +12.2%, PLUG +11.5%, BLDP +10.5%, CBAK +2.5%
Other news: LJPC +63.9% (reports positive, top-line results from Phase 2 Clinical Trial of GCS-100 in chronic kidney disease; primary efficacy endpoint of improved kidney function achieved), RCON +22.6% (Recon Technology's BHD division receives new authorization to provide fracturing equipment and services for SinopeC), HOTR +19.3% (modestly rebounding), DSS +11.6% (files patent infringement claim against Samsung (SSNLF), TSMC, and NEC), UQM +10.4% (continued strength), BYD +8.5% (Elliott Associates and Elliott International disclosed a combined 4.99% stake), RGSE +7.1% (continued strength), RNN +6.4% (Announces Initial Results from Phase I Trial of Supinoxin (RX-5902) for Solid Cancer Tumors; Supinoxin is safe and well tolerated over the dose range tested in cancer patients), PPHM +4.2% ( Data Presentations at Keystone Symposium Support Potential of co's PS-Targeting Antibodies to Overcome Immune Suppression and Enhance Anti-Tumor Activity of Anti-CTLA-4 and PD-1 Antibodies), GTAT +2.9% (Signs Agreement to Supply $336 Million of Equipment and Technology for a 25,000 MTA Polysilicon Production Facility in Sarawak, Malaysia), EXXI +1.7% ( positive comments on Mad Money), BBRY +1.3% (has sold its US HQ in Las Colinas, according to reports), KYTH +1.1% (acquired rights to ATX-101 outside of the U.S. and Canada from Bayer (BAYRY) Consumer Care), MSG +0.8% ( Sean 'Diddy' Combs bid ~$200 mln for the MSG owned Fuse cable-TV channel, according to reports), DATA +0.4% ( JANA Partners discloses sale of 2 mln shares at $68 on 3/6).
Analyst comments: JCP +6.9% (upgraded to Buy from Neutral at Citigroup), ITMN +4% (upgraded to Buy from Neutral at Goldman), DDD +2.7% ( upgraded to Overweight from Equal Weight at a boutique firm), GWPH +2.1% (initiated with a Buy at BofA/Merrill), ARO +1.4% ( initiated with a Buy at Buckingham Research), BLOX +0.9% (Infoblox initiated with an Overweight at Piper Jaffray),M +0.8% (upgraded to Outperform from Market Perform at Wells Fargo), AAPL +0.7% (upgraded to Outperform from Sector Perform at Pacific Crest), FB +0.7% (target raised to $85 from $70 at Citigroup), RFMD +0.7% ( initiated with a Buy at Ascendiant Capital Markets)